Clinical Trial

Bioequivalence Study of AG2202

Not Yet Recruiting Phase 1
View on ClinicalTrials.gov →
Record status
This record was last updated August 14, 2024 (before its estimated September 2024 completion). Its status may not reflect the trial's current state.
Summary
The objective of this study is to evaluate the human bioequivalence of AG2202T and AG2202R.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-08-09.
Trial Details
NCT Number NCT06549504
Lead Sponsor Ahn-Gook Pharmaceuticals Co.,Ltd
Conditions Bioequivalence Study
Enrollment 34 participants
Start Date 2024-08
Primary Completion 2024-09 (estimated)
Study Completion 2024-09 (estimated)
Updated on ClinicalTrials.gov 2024-08-14